Potential molecular tools for assessing the public health risk associated with waterborne Cryptosporidium oocysts

Journal of Medical Microbiology

Volumn 61, Issue 8, 2012, Pages 1039-1051

  Kothavade, Rajendra J ^a  

^a EPCOR   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DRINKING WATER; HEAT SHOCK PROTEIN 70; MESSENGER RNA; OZONE; RNA 18S;

CELL CULTURE; CHLORINATION; CLINICAL ASSESSMENT; COCCIDIA; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM CANIS; CRYPTOSPORIDIUM FELIS; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM MELEAGRIDIS; CRYPTOSPORIDIUM PARVUM; CRYPTOSPORIDIUM SUIS; DISINFECTION; DNA EXTRACTION; GENETIC VARIABILITY; GENOTYPE; GIARDIA; HEALTH HAZARD; HUMAN; IN VITRO STUDY; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MICROSCOPY; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; OOCYST; PARASITE IDENTIFICATION; PARASITE ISOLATION; PARASITE TRANSMISSION; PRIORITY JOURNAL; PROTOZOON; PUBLIC HEALTH; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; ULTRAVIOLET IRRADIATION; WATER CONTAMINATION; WATER TREATMENT;

CELL SURVIVAL; CRYPTOSPORIDIUM; DISINFECTION; GENOTYPE; GIARDIA; HUMANS; OOCYSTS; PARASITOLOGY; RISK ASSESSMENT; UNITED STATES; WATER; WATER PURIFICATION;

EID: 84864085382     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.043158-0     Document Type: Review

References (102)

1. Aboytes, R., Di Giovanni, G. D., Abrams, F. A. & LeChevallier, M. W. (2004). Detection of infectious Cryptosporidium in filtered drinking water. J Am Water Works Assoc 96, 88-98.
2. Ahmed, W., Vieritz, A., Goonetilleke, A. & Gardner, T. (2010). Health risk from the use of roof-harvested rainwater in Southeast Queensland, Australia, as potable or nonpotable water, determined using quantitative microbial risk assessment. Appl Environ Microbiol 76, 7382-7391.
3. Alagappan, A., Bergquist, P. L. & Ferrari, B. C. (2009). Development of a two-color fluorescence in situ hybridization technique for species-level identification of human-infectious Cryptosporidium spp. Appl Environ Microbiol 75, 5996-5998.
4. Anceno, A. J., Ozaki, M., Dang, Y. N., Chuluun, B. & Shipin, O. V. (2007). Canal networks as extended waste stabilization ponds: fate of pathogens in constructed waterways in Pathumthani Province, Thailand. Water Sci Technol 55, 143-156.
5. Arrowood, M. J. (2002). In vitro cultivation of Cryptosporidium species. Clin Microbiol Rev 15, 390-400.
6. Bakheit, M. A., Torra, D., Palomino, L. A., Thekisoe, O. M., Mbati, P. A., Ongerth, J. & Karanis, P. (2008). Sensitive and specific detection of Cryptosporidium species in PCR-negative samples by loop-mediated isothermal DNA amplification and confirmation of generated LAMP products by sequencing. Vet Parasitol 158, 11-22.
7. Bandyopadhyay, K., Kellar, K. L., Moura, I., Casaqui Carollo, M. C., Graczyk, T. K., Slemenda, S., Johnston, S. P. & da Silva, A. J. (2007). Rapid microsphere assay for identification of Cryptosporidium hominis and Cryptosporidium parvum in stool and environmental samples. J Clin Microbiol 45, 2835-2840.
8. Belosevic, M., Faubert, G. M., MacLean, J. D., Law, C. & Croll, N. A. (1983). Giardia lamblia infections in Mongolian gerbils: an animal model. J Infect Dis 147, 222-226.
9. Belosevic, M., Craik, S. A., Stafford, J. L., Neumann, N. F., Kruithof, J. & Smith, D. W. (2001). Studies on the resistance/reactivation of Giardia muris cysts and Cryptosporidium parvum oocysts exposed to medium-pressure ultraviolet radiation. FEMS Microbiol Lett 204, 197-203.
10. Black, E. K., Finch, G. R., Taghi-Kilani, R. & Belosevic, M. (1996). Comparison of assays for Cryptosporidium parvum oocysts viability after chemical disinfection. FEMS Microbiol Lett 135, 187-189.
11. Budu-Amoako, E., Greenwood, S. J., Dixon, B. R., Barkema, H. W. & McClure, J. T. (2011). Foodborne illness associated with Cryptosporidium and Giardia from livestock. J Food Prot 74, 1944-1955.
12. Bukhari, Z. & LeChevallier, M. (2003). Assessing UV reactor performance for treatment of finished water. Water Sci Technol 47, 179-184.
13. Burton, A. J., Nydam, D. V., Dearen, T. K., Mitchell, K., Bowman, D. D. & Xiao, L. (2010). The prevalence of Cryptosporidium, and identification of the Cryptosporidium horse genotype in foals in New York State. Vet Parasitol 174, 139-144.
14. Cacciò, S. M. (2005). Molecular epidemiology of human cryptosporidiosis. Parassitologia 47, 185-192.
15. Cama, V. A., Ross, J. M., Crawford, S., Kawai, V., Chavez-Valdez, R., Vargas, D., Vivar, A., Ticona, E., Navincopa, M. & other authors (2007). Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis 196, 684-691.
16. Campbell, A. T., Robertson, L. J. & Smith, H. V. (1992). Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Appl Environ Microbiol 58, 3488-3493.
17. CCME (2002). From Source to Tap-The multi-barrier approach to safe drinking water. Federal-Provincial-Territorial Committee on Drinking Water of the Federal-Provincial-Territorial Committee on Environmental and Occupational Health and the Water Quality Task Group of the Canadian Council of Ministers of the Environment.
18. Chappell, C. L., Okhuysen, P. C., Sterling, C. R. & DuPont, H. L. (1996). Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 173, 232-236.
19. Chappell, C. L., Okhuysen, P. C., Langer-Curry, R., Widmer, G., Akiyoshi, D. E., Tanriverdi, S. & Tzipori, S. (2006). Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 75, 851-857.
20. Chappell, C. L., Okhuysen, P. C., Langer-Curry, R. C., Akiyoshi, D. E., Widmer, G. & Tzipori, S. (2011). Cryptosporidium meleagridis: infectivity in healthy adult volunteers. Am J Trop Med Hyg 85, 238-242.
21. Clark, D. P. (1999). New insights into human cryptosporidiosis. Clin Microbiol Rev 12, 554-563.
22. Clark, W. F., Sontrop, J. M., Macnab, J. J., Salvadori, M., Moist, L., Suri, R. & Garg, A. X. (2010). Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study. BMJ 17, 341.
23. Connelly, J. T., Nugen, S. R., Borejsza-Wysocki, W., Durst, R. A., Montagna, R. A. & Baeumner, A. J. (2008). Human pathogenic Cryptosporidium species bioanalytical detection method with single oocyst detection capability. Anal Bioanal Chem 391, 487-495.
24. Di Giovanni, G. D. & LeChevallier, M. W. (2005). Quantitative-PCR assessment of Cryptosporidium parvum cell culture infection. Appl Environ Microbiol 71, 1495-1500.
25. Di Giovanni, G. D., Hashemi, F. H., Shaw, N. J., Abrams, F. A., LeChevallier, M. W. & Abbaszadegan, M. (1999). Detection of infectious Cryptosporidium parvum oocysts in surface and filter backwash water samples by immunomagnetic separation and integrated cell culture-PCR. Appl Environ Microbiol 65, 3427-3432.
26. Di Giovanni, G. D., Hoffman, R. H. & Sturbaum, G. D. (2010). Cryptosporidium Genotyping Method for Regulatory Microscope Slides. Denver, CO. Water Research Foundation and USEPA. (http://www.waterrf.org/ProjectsReports/PublicReportLibrary/4099.pdf).
27. Diamond, L. S., Harlow, D. R. & Cunnick, C. C. (1978). A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72, 431-432.
28. DuPont, H. L., Chappell, C. L., Sterling, C. R., Okhuysen, P. C., Rose, J. B. & Jakubowski, W. (1995). The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 332, 855-859.
29. Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E. & other authors (2006). Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 19, 165-256.
30. Fayer, R. (2004). Cryptosporidium: a water-borne zoonotic parasite. Vet Parasitol 126, 37-56.
31. Ferguson, C., Deere, D., Sinclair, M., Chalmers, R. M., Elwin, K., Hadfield, S., Xiao, L., Ryan, U., Gasser, R. & other authors (2006). Meeting report: application of genotyping methods to assess risks from Cryptosporidium in watersheds. Environ Health Perspect 114, 430-434.
32. Finch, G. R., Daniels, C. W., Black, E. K., Schaefer, F. W., III & Belosevic, M. (1993). Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice. Appl Environ Microbiol 59, 3661-3665.
33. FDA (2009). FDA Food Code 2009: Annex 3-Public Health Reasons /Administrative Guidelines, Chapter 3-Food (3-301: Preventing contamination by employees; 3-301.11-Preventing contamination from hands). U.S. Food and Drug Administration, Silver Spring MD.
34. Garvey, M., Farrell, H., Cormican, M. & Rowan, N. (2010). Investigations of the relationship between use of in vitro cell culture-quantitative PCR and a mouse-based bioassay for evaluating critical factors affecting the disinfection performance of pulsed UV light for treating Cryptosporidium parvum oocysts in saline. J Microbiol Methods 80, 267-273.
35. Gatei, W., Greensill, J., Ashford, R. W., Cuevas, L. E., Parry, C. M., Cunliffe, N. A., Beeching, N. J. & Hart, C. A. (2003). Molecular analysis of the 18S rRNA gene of Cryptosporidium parasites from patients with or without human immunodeficiency virus infections living in Kenya, Malawi, Brazil, the United Kingdom, and Vietnam. J Clin Microbiol 41, 1458-1462.
36. Gennaccaro, A. L., McLaughlin, M. R., Quintero-Betancourt, W., Huffman, D. E. & Rose, J. B. (2003). Infectious Cryptosporidium parvum oocysts in final reclaimed effluent. Appl Environ Microbiol 69, 4983-4984.
37. Griffiths, J. K. (1998). Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis. Adv Parasitol 40, 37-85.
38. Hadfield, S. J., Robinson, G., Elwin, K. & Chalmers, R. M. (2011). Detection and differentiation of Cryptosporidium spp. in human clinical samples by use of real-time PCR. J Clin Microbiol 49, 918-924.
39. Hallier-Soulier, S. & Guillot, E. (2000). Detection of cryptosporidia and Cryptosporidium parvum oocysts in environmental water samples by immunomagnetic separation-polymerase chain reaction. J Appl Microbiol 89, 5-10.
40. Harhay, M. O., Horton, J., Olliaro, P. L. & Utzinger, J. (2011). Diagnostics are central for a truly holistic approach against intestinal parasitic diseases. Int J Infect Dis 15, e76-e77.
41. Heitman, T. L., Frederick, L. M., Viste, J. R., Guselle, N. J., Morgan, U. M., Thompson, R. C. & Olson, M. E. (2002). Prevalence of Giardia and Cryptosporidium and characterization of Cryptosporidium spp. isolated from wildlife, human, and agricultural sources in the North Saskatchewan River Basin in Alberta, Canada. Can J Microbiol 48, 530-541.
42. Jakubowski, W. (1995). "Giardia and Cryptosporidium: the details." 1995 Safe Drinking Water Act Seminar. U.S. Environmental Protection Agency.
43. Jenkins, M. B., Anguish, L. J., Bowman, D. D., Walker, M. J. & Ghiorse, W. C. (1997). Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts. Appl Environ Microbiol 63, 3844-3850.
44. Jenkins, M. B., Liotta, J. L., Lucio-Forster, A. & Bowman, D. D. (2010). Concentrations, viability, and distribution of Cryptosporidium genotypes in lagoons of swine facilities in the Southern Piedmont and in coastal plain watersheds of Georgia. Appl Environ Microbiol 76, 5757-5763.
45. Johnson, D. W., Pieniazek, N. J., Griffin, D. W., Misener, L. & Rose, J. B. (1995). Development of a PCR protocol for sensitive detection of Cryptosporidium oocysts in water samples. Appl Environ Microbiol 61, 3849-3855.
46. Johnson, A. M., Giovanni, G. D. & Rochelle, P. A. (2012). Comparison of assays for sensitive and reproducible detection of cell culture-infectious Cryptosporidium parvum and Cryptosporidium hominis in drinking water. Appl Environ Microbiol 78, 156-162.
47. Karanis, P., Thekisoe, O., Kiouptsi, K., Ongerth, J., Igarashi, I. & Inoue, N. (2007). Development and preliminary evaluation of a loop-mediated isothermal amplification procedure for sensitive detection of Cryptosporidium oocysts in fecal and water samples. Appl Environ Microbiol 73, 5660-5662.
48. Kato, S., Jenkins, M. B., Ghiorse, W. C. & Bowman, D. D. (2001). Chemical and physical factors affecting the excystation of Cryptosporidium parvum oocysts. J Parasitol 87, 575-581.
49. Khramtsov, N. V., Tilley, M., Blunt, D. S., Montelone, B. A. & Upton, S. J. (1995). Cloning and analysis of a Cryptosporidium parvum gene encoding a protein with homology to cytoplasmic form Hsp70. J Eukaryot Microbiol 42, 416-422.
50. Kong, F. & Gilbert, G. L. (2007). Multiplex PCR-based reverse line blot hybridization assay (mPCR/RLB)-a practical epidemiological and diagnostic tool. Nat Protoc 1, 2668-2680.
51. Kothavade, R. J. (2011). Challenges in understanding the immune-pathogenesis of Cryptosporidium infections in humans. Eur J Clin Microbiol Infect Dis 30, 1461-1472.
52. Krometis, L. A., Characklis, G. W. & Sobsey, M. D. (2009). Identification of particle size classes inhibiting protozoan recovery from surface water samples via US Environmental Protection Agency method 1623. Appl Environ Microbiol 75, 6619-6621.
53. Lalancette, C., Di Giovanni, G. D. & Prévost, M. (2010). Improved risk analysis by dual direct detection of total and infectious Cryptosporidium oocysts on cell culture in combination with immunofluorescence assay. Appl Environ Microbiol 76, 566-577.
54. Laupland, K. B. (2004). Population-based epidemiology of intensive care: critical importance of ascertainment of residency status. Crit Care 8, R431-R436.
55. Laupland, K. B. & Church, D. L. (2005). Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect Dis 5, 72.
56. Leone, A., Ripabelli, G., Sammarco, M. L. & Grasso, G. M. (2009). Detection of Cryptosporidium spp. from human faeces by PCR-RFLP, cloning and sequencing. Parasitol Res 104, 583-587.
57. Li, D., Craik, S. A., Smith, D. W. & Belosevic, M. (2008). Survival of Giardia lamblia trophozoites after exposure to UV light. FEMS Microbiol Lett 278, 56-61.
58. Lim, Y. A., Iqbal, A., Surin, J., Sim, B. L., Jex, A. R., Nolan, M. J., Smith, H. V. & Gasser, R. B. (2011). First genetic classification of Cryptosporidium and Giardia from HIV/AIDS patients in Malaysia. Infect Genet Evol 11, 968-974.
59. Llorente, M. T., Clavel, A., Goñi, M. P., Varea, M., Seral, C., Becerril, R., Suarez, L. & Gómez-Lus, R. (2007). Genetic characterization of Cryptosporidium species from humans in Spain. Parasitol Int 56, 201-205.
60. Mak, J. W. (2004). Important zoonotic intestinal protozoan parasites in Asia. Trop Biomed 21, 39-50.
61. McCuin, R. M. & Clancy, J. L. (2006). Occurrence of Cryptosporidium oocysts in US wastewaters. J Water Health 4, 437-452.
62. Medema, G., Teunis, P., Blokker, M., Deere, D., Davison, A., Charles, P. & Loret, J. F. (2006). WHO Guidelines for drinking water quality: Cryptosporidium. WHO, 138. New York 2006.
63. Mens, P. F., Schoone, G. J., Kager, P. A. & Schallig, H. D. (2006). Detection and identification of human Plasmodium species with real-time quantitative nucleic acid sequence-based amplification. Malar J 5, 80.
64. Morgan-Ryan, U. M., Fall, A., Ward, L. A., Hijjawi, N., Sulaiman, I., Fayer, R., Thompson, R. C., Olson, M., Lal, A. & Xiao, L. (2002). Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot Microbiol 49, 433-440.
65. Nago, T. T., Tokashiki, Y. T., Kisanuki, K., Nakasone, I. & Yamane, N. (2010). [Laboratory-based evaluation of loop-mediated isothermal amplification (LAMP) to detect Cryptosporidium oocyst and Giardia lamblia cyst in stool specimens]. Rinsho Byori 58, 765-771 (in Japanese).
66. Neira, P., Munoz, N. & Rosales, J. (2010). [Cryptosporidium parvum infection in a pregnant immunocompetent woman with occupational risk]. Rev Chilena Infectol 27, 345-349 (in Spanish).
67. Neumann, N. F., Gyurek, L. L., Gammie, L., Finch, G. R. & Belosevic, M. (2000). Comparison of animal infectivity and nucleic acid staining for assessment of Cryptosporidium parvum viability in water. Appl Environ Microbiol 66, 406-412.
68. Notomi, T., Okayama, H., Masubuchi, H., Yonekawa, T., Watanabe, K., Amino, N. & Hase, T. (2000). Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28, e63.
69. Okhuysen, P. C., Chappell, C. L., Sterling, C. R., Jakubowski, W. & DuPont, H. L. (1998). Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun 66, 441-443.
70. Paziewska, A., Bednarska, M., Nieweglowski, H., Karbowiak, G. & Bajer, A. (2007). Distribution of Cryptosporidium and Giardia spp. in selected species of protected and game mammals from North-eastern Poland. Ann Agric Environ Med 14, 265-270.
71. Pedraza-Díaz, S., Amar, C., Nichols, G. L. & McLauchlin, J. (2001). Nested polymerase chain reaction for amplification of the Cryptosporidium oocyst wall protein gene. Emerg Infect Dis 7, 49-56.
72. Peng, M. M., Xiao, L., Freeman, A. R., Arrowood, M. J., Escalante, A. A., Weltman, A. C., Ong, C. S. L., Mac Kenzie, W. R., Lal, A. A. & Beard, C. B. (1997). Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis 3, 567-573.
73. Pierce, K. K. & Kirkpatrick, B. D. (2009). Update on human infections caused by intestinal protozoa. Curr Opin Gastroenterol 25, 12-17.
74. Pirestani, M., Sadraei, J., Dalimi Asl, A., Zavvar, M. & Vaeznia, H. (2008). Molecular characterization of Cryptosporidium isolates from human and bovine using 18s rRNA gene in Shahriar county of Tehran, Iran. Parasitol Res 103, 467-472.
75. Quintero-Betancourt, W., Gennaccaro, A. L., Scott, T. M. & Rose, J. B. (2003). Assessment of methods for detection of infectious Cryptosporidium oocysts and Giardia cysts in reclaimed effluents. Appl Environ Microbiol 69, 5380-5388.
76. Raccurt, C. P., Brasseur, P., Verdier, R. I., Li, X., Eyma, E., Stockman, C. P., Agnamey, P., Guyot, K., Totet, A. & other authors (2006). [Human cryptosporidiosis and Cryptosporidium spp. in Haiti]. Trop Med Int Health 11, 929-934 (in French).
77. Rochelle, P. A., Ferguson, D. M., Handojo, T. J., De Leon, R., Stewart, M. H. & Wolfe, R. L. (1997). An assay combining cell culture with reverse transcriptase PCR to detect and determine the infectivity of waterborne Cryptosporidium parvum. Appl Environ Microbiol 63, 2029-2037.
78. Rochelle, P. A., Marshall, M. M., Mead, J. R., Johnson, A. M., Korich, D. G., Rosen, J. S. & De Leon, R. (2002). Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum. Appl Environ Microbiol 68, 3809-3817.
79. Rochelle, P. A., Fallar, D., Marshall, M. M., Montelone, B. A., Upton, S. J. & Woods, K. (2004). Irreversible UV inactivation of Cryptosporidium spp. despite the presence of UV repair genes. J Eukaryot Microbiol 51, 553-562.
80. Schuster, C. J., Ellis, A. G., Robertson, W. J., Charron, D. F., Aramini, J. J., Marshall, B. J. & Medeiros, D. T. (2005). Infectious disease outbreaks related to drinking water in Canada, 1974-2001. Can J Public Health 96, 254-258.
81. Sifuentes, L. Y. & Di Giovanni, G. D. (2007). Aged HCT-8 cell monolayers support Cryptosporidium parvum infection. Appl Environ Microbiol 73, 7548-7551.
82. Skotarczak, B. (2009). Methods for parasitic protozoans detection in the environmental samples. Parasite 16, 183-190.
83. Skotarczak, B. (2010). Progress in the molecular methods for the detection and genetic characterization of Cryptosporidium in water samples. Ann Agric Environ Med 17, 1-8.
84. Slifko, T. R., Friedman, D., Rose, J. B. & Jakubowski, W. (1997). An in vitro method for detecting infectious Cryptosporidium oocysts with cell culture. Appl Environ Microbiol 63, 3669-3675.
85. Sréter, T., Kovács, G., da Silva, A. J., Pieniazek, N. J., Széll, Z., Dobos-Kovács, M., Márialigeti, K. & Varga, I. (2000) Morphologic, host specificity, and molecular characterization of a Hungarian Cryptosporidium meleagridis isolate. Appl Environ Microbiol 66, 735-738.
86. Steiner, T. S., Thielman, N. M. & Guerrant, R. L. (1997). Protozoal agents: what are the dangers for the public water supply? Annu Rev Med 48, 329-340.
87. Stinear, T., Matusan, A., Hines, K. & Sandery, M. (1996). Detection of a single viable Cryptosporidium parvum oocyst in environmental water concentrates by reverse transcription-PCR. Appl Environ Microbiol 62, 3385-3390.
88. Sunnotel, O., Lowery, C. J., Moore, J. E., Dooley, J. S., Xiao, L., Millar, B. C., Rooney, P. J. & Snelling, W. J. (2006a). Cryptosporidium. Lett Appl Microbiol 43, 7-16.
89. Sunnotel, O., Snelling, W. J., Xiao, L., Moule, K., Moore, J. E., Millar, B. C., Dooley, J. S. G. & Lowery, C. J. (2006b). Rapid and sensitive detection of single Cryptosporidium oocysts from archived glass slides. J Clin Microbiol 44, 3285-3291.
90. Upton, S. J., Tilley, M. & Brillhart, D. B. (1995). Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells. J Clin Microbiol 33, 371-375.
91. USEPA (1996). National primary drinking water regulation: monitoring requirements for public drinking water suppliers: Cryptosporidium, Giardia, viruses, disinfection by-products, water treatment plant data and other information requirements. Fed Regist 61, 24354-24388.
92. USEPA (1997). Draft method 1622: Cryptosporidium in water by filtration/IMS/FA. Washington, DC: Office of Research and Development, U.S. Government Printing Office.
93. USEPA (1999). Wastewater technology fact sheet ultraviolet disinfection. Office of water, Washington, DC: EPA, 832-F-99-064.
94. USEPA (2005). Method 1623: Cryptosporidium and Giardia in water by filtration/IMS/FA. EPA 815-R-05-002. Washington, DC: Office of Research and Development, Government Printing Office.
95. USEPA (2006). Ultraviolet disinfection guidance manual for the final long term 2 enhanced surface water treatment rule. Washington, DC: United States Environmental Protection Agency.
96. USEPA (2007). Literature review of molecular methods for simultaneous detection of pathogens in water. USEPA workshop on innovative approaches for detecting microorganisms in water, Cincinnati, OH: EPA/6000/R-07/128.
97. Wagner-Wiening, C. & Kimmig, P. (1995). Detection of viable Cryptosporidium parvum oocysts by PCR. Appl Environ Microbiol 61, 4514-4516.
98. WHO. (2009). Risk assessment of Cryptosporidium in drinking water, WHO/HSE/WSH/09.04, 1-134.
99. Woods, K. M. & Upton, S. J. (2007). In vitro development of Cryptosporidium parvum in serum-free media. Lett Appl Microbiol 44, 520-523.
100. Xiao, L., Bern, C., Limor, J., Sulaiman, I., Roberts, J., Checkley, W., Cabrera, L., Gilman, R. H. & Lal, A. A. (2001). Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis 183, 492-497.
101. Xiao, L., Sulaiman, I. M., Ryan, U. M., Zhou, L., Atwill, E. R., Tischler, M. L., Zhang, X., Fayer, R. & Lal, A. A. (2002). Host adaptation and host-parasite co-evolution in Cryptosporidium: implications for taxonomy and public health. Int J Parasitol 32, 1773-1785.
102. Xiao, L., Fayer, R., Ryan, U. & Upton, S. J. (2004). Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev 17, 72-97.